Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

The SYK Switch: How Sovleplenib Is Rewiring Immune Responses in Disease

Exploring the groundbreaking development of sovleplenib, a highly selective SYK inhibitor transforming treatment for autoimmune diseases and cancers.

Connor Hughes
Aug 11, 2025

Popular Articles